Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

More Than $47M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying

Published 05/05/2023, 14:02
Updated 05/05/2023, 15:10
© Reuters.  More Than $47M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
ATVI
-
GD
-
HHH
-
GDBR34
-
MORF
-
ATVI34
-

Benzinga - Although US stocks closed lower on Thursday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

Morphic Holding

  • The Trade: Morphic Holding, Inc. (NASDAQ: MORF) Director Timothy A Springer acquired a total 1,050,000 shares an average price of $45.00. To acquire these shares, it cost around $47.25 million.
  • What’s Happening: Morphic raised $240 million via secondary share sale of 5.3 million shares at $45.00 per share.
  • What Morphic Holding Does: Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics.
Howard Hughes
  • The Trade: The Howard Hughes Corporation (NYSE: HHC) Director William Ackman acquired a total of 31,083 shares at an average price of $74.72. To acquire these shares, it cost around $2.32 million.
  • What’s Happening: The Howard Hughes is expected to release Q1 earnings on May 8, 2023, after the market closes.
  • What Howard Hughes Does: The Howard Hughes Corp is a real estate company that develops master-planned communities (MPCs) and is involved in other strategic real estate development opportunities across the United States.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Activision Blizzard

  • The Trade: Activision Blizzard, Inc. (NASDAQ: ATVI) Director Peter J Nolan bought a total of 13,160 shares at an average price of $75.99. To acquire these shares, it cost around $1 million.
  • What’s Happening: Stifel recently maintained Activision Blizzard with a Buy and lowered the price target from $95 to $88.
  • What Activision Blizzard Does: Activision Blizzard was formed in 2008 by the merger of Activision, one of the largest console video game publishers, and Blizzard, one of largest PC video game publishers.

Check This Out: Apple, Kellogg And 3 Stocks To Watch Heading Into Thursday

General Dynamics

  • The Trade: General Dynamics Corporation (NYSE: GD) Director Mark Malcolm bought a total 4,700 shares at an average price of $214.47. The insider spent around $1.01 million to buy those shares.
  • What’s Happening: General Dynamics reported first-quarter FY23 revenue growth of 5.2% year-over-year to $9.88 billion, beating the consensus of $9.33 billion.
  • What General Dynamics Does: General Dynamics is a defense contractor and business jet manufacturer. The firm's segments include aerospace, marine, combat systems, and technologies.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.